Research Article
Detection of IL-17 in clinical and subclinical hypothyroid Iraqi patients
- By Eman. K. Matshar, Nawras Kadhim Rassin, Ban Samary Atyah - 22 Jul 2024
- Journal of Biomedicine and Biosensors, Volume: 4, Issue: 3, Pages: 11 - 16
- https://doi.org/10.58613/jbb432
- Received: May 9, 2024; Accepted: July 14, 2024; Published: July 22, 2024
Abstract
The current realization was implemented out to assess the level of Interleukin17 (IL-17) in hypothyroidism Iraqi patients taking into account various thyroid functioning states (Clinical hypothyroidism and subclinical hypothyroidism). Include 84 individuals who have been clinically identified to check hypothyroid disoorder. Three research groups have been examined. Of various ages, there were 48 clinical hypothyroid patients, 13 subclinical hypothyroid patients, and 23 healthy persons. According to this study, of all patients, the percentage of females (83.3%) with subclinical hypothyroidism and the percentage of males (16.7%) with clinical hypothyroidism and subclinical hypothyroidism, respectively, are higher than The T4 level in the subclinical group compared to the level of healthy group is not noteworthy different from the T3 level in any of the three groups, according to the results. When compared to the other two groups' levels, the clinical hypothyroid patients exhibit the lowest level of T4, with a significant difference. When comparing the TSH level of clinical hypothyroid individuals to that of the other two groups, there is a notable difference in the former group.We can notice a significant elevated in level of IL-17 in clinical hypothyroidism, on the contrary, subclinical hypothyroid have a lower level of IL-17 than in healthy subjects.